
December 2013
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Pembrolizumab Plus Enfortumab Vedotin for MIBC
2
Global CKD Burden Nearly Doubles Since 1990, Reaching 788 Million Adults Worldwide
3
CAR T-Cell Therapies, Bispecific Antibodies Usher in New Era in R/R MCL
4
Pediatric AD Data Show Strong Safety and Efficacy for Tapinarof Cream: Druhan Howell, MD
5



